Vitamin D status and response to supplementation in very preterm infants: A prospective cohort study

Suphawe Wasuanankun1, Prattana Rattanachamnongk2, Buranee Yangthara3

  • 1Department of Pediatrics, Golden Jubilee Medical Center, Mahidol University, Nakhon Pathom, Thailand.

Insights

Vitamin D deficiency is common in very preterm infants. Daily intake under 400 IU/kg typically normalizes vitamin D levels by 8 weeks, reducing risks associated with deficiency and excess.

Area of Science:

  • Neonatology
  • Pediatric Endocrinology
  • Nutritional Science

Background:

  • Very preterm infants face high risks of vitamin D deficiency (VDD), contributing to metabolic bone disease (MBD) and other complications.
  • Optimal vitamin D dosing for these infants remains unclear despite existing guidelines.
  • This study investigated VDD incidence and 25-hydroxyvitamin D [25(OH)D] responses to different vitamin D intakes in early life.

Purpose of the Study:

  • To determine the incidence of vitamin D deficiency (VDD) in very preterm infants.
  • To evaluate the impact of varying vitamin D intakes on serum 25-hydroxyvitamin D [25(OH)D] levels within the first 8 weeks of life.
  • To assess the safety and efficacy of different vitamin D supplementation regimens.

Main Methods:

  • A prospective cohort study of infants born before 32 weeks' gestation or with birth weight under 1500g.
  • Infants were grouped by total vitamin D intake (parenteral and enteral) during weeks 0-4: <400, 400-700, or >700 IU/kg/day.
  • Serum 25(OH)D levels were measured at birth, 4 weeks, and 8 weeks; VDD was defined as <20 ng/mL and vitamin D excess (VDE) as >100 ng/mL.

Main Results:

  • High VDD prevalence at birth (94.3%). At 4 weeks, VDD persisted in 17.8% (<400 IU/kg/day) and 6.5% (400-700 IU/kg/day), with minimal VDE.
  • By 8 weeks, 90.1% achieved normal 25(OH)D with <400 IU/kg/day, compared to 77.4% with 400-700 IU/kg/day.
  • Higher intakes (400-700 IU/kg/day) led to increased VDE (22.6%) by 8 weeks; MBD occurred in only one infant.

Conclusions:

  • VDD is nearly universal at birth in very preterm infants.
  • A daily intake of less than 400 IU/kg effectively normalized vitamin D status by 8 weeks, minimizing risks of both deficiency and excess.
  • Higher vitamin D doses did not offer additional benefits and increased the risk of vitamin D excess.
Abstract

Related Concept Videos

Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
9.0K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
886
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
6.1K
Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
4.6K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.3K